2-Year survival benefit from immunotherapy for squamous cell cancer with cancer of unknown primary in mediastinum: a case report

Cancers of unknown primary (CUP) account for 2%–5% of all diagnosed cancers and are always characterized with fast-paced aggression, early metastasis, and unpredictable spread patterns Mediastinum metastasis with unknown primary origin is extremely rare and with a poor prognosis and short survival....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Wei, Zhao, Nan, Zhang, Manze, Li, Zhihua, Wang, Ning, Shen, Wennan, Dong, Yuemei, Nie, Yanli, Li, Zhaoxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598860/
https://www.ncbi.nlm.nih.gov/pubmed/37886174
http://dx.doi.org/10.3389/fonc.2023.1242460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598860/
https://www.ncbi.nlm.nih.gov/pubmed/37886174
http://dx.doi.org/10.3389/fonc.2023.1242460

Ejemplares similares